ArticleFrontiers in human neuroscience2026
EEG-based brain-computer interface with immersive virtual reality for phantom limb pain: a single-center pilot neurofeedback trial.
Article in Frontiers in human neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Phantom limb pain (PLP) is a challenging neuropathic pain condition following limb amputation or brachial plexus injury. Non-pharmacological interventions such as motor imagery training, phantom motor execution and mirror therapy have shown potential to alleviate PLP by engaging sensorimotor circuits, but their effects are debated. We developed GHOST, a portable EEG-based brain-computer interface (BCI) coupled with immersive virtual reality (VR), allowing patients to control a virtual limb via motor imagery in real time, as a neurofeedback-based rehabilitation tool. Methods: We conducted a single-center exploratory pilot trial to assess the feasibility and preliminary efficacy of this device. Seven patients with chronic upper-limb PLP (amputees or brachial plexus avulsion, pain ≥3/10) underwent 10 training sessions over 2 weeks. Daily pain diaries (distinguishing continuous pain vs. paroxysmal pain episodes) were recorded for 1 month before and 1 month after the intervention, with follow-up to 6 months. Motor imagery ability, anxiety-depression (HADS), and quality of life (SF-36) were also evaluated. Results: Six patients completed ≥8 sessions. All participants achieved BCI control of the virtual hand, with high success rates (>70%) even as task difficulty increased, demonstrating system feasibility. No adverse events occurred. Compared to baseline, patients experienced a significant short-term reduction in paroxysmal pain (frequency and intensity of pain "flare-ups"), with up to >80% median decrease in weekly cumulated pain episode intensity ( Conclusion: This pilot study supports the safety and feasibility of EEG-BCI with VR for PLP and suggests that it can yield short-term analgesic effects, particularly on paroxysmal pain. These findings support the hypothesis that sensorimotor re-engagement could effectively target maladaptive neural processes underlying PLP, while warranting confirmation in controlled trials. Future work will optimize the training protocol and investigate neuroplastic changes associated with this BCI-VR intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.